Vmn1r128 Activators
Vmn1r128 activators enhance the functional activity of vomeronasal 1 receptor 128 through various biochemical and cellular pathways. Compounds like L-Arginine and Sodium nitroprusside raise nitric oxide levels, which in turn activate guanylyl cyclase. The resultant increase in cGMP levels enhances vomeronasal 1 receptor 128 activity by facilitating cGMP-dependent protein kinase signaling. Phosphodiesterase inhibitors such as Sildenafil and Zaprinast maintain elevated cGMP levels, which further support the activity of vomeronasal 1 receptor 128 through similar pathways. Caffeine, by inhibiting phosphodiesterase enzymes, amplifies the effects of cAMP and cGMP, thereby indirectly enhancing the activity of the receptor through increased PKA and PKG activity. Forskolin and Isoproterenol function by elevating cAMP levels, which activate PKA, potentially leading to thephosphorylation of proteins that could be part of the signaling cascade associated with vomeronasal 1 receptor 128, thus enhancing its functional activity.
Calcium signaling modulators such as A23187 (Calcimycin) and BAPTA-AM manipulate intracellular calcium levels, which is crucial for the activation of calcium/calmodulin-dependent protein kinases that can influence vomeronasal 1 receptor 128 activity. A23187 increases calcium influx, while BAPTA-AM, after hydrolysis, binds calcium and could induce compensatory mechanisms that enhance calcium signaling. Niflumic acid, by inhibiting chloride channels, alters cellular ionic balance, potentially triggering signaling cascades that culminate in the activation of vomeronasal 1 receptor 128. Nicotine engages with nicotinic acetylcholine receptors to promote depolarization and an increase in intracellular calcium, another route through which vomeronasal 1 receptor 128 activity can be enhanced.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
L-Arginine serves as a substrate for nitric oxide synthase, which leads to the production of nitric oxide, a diffusible second messenger that can increase the activity of guanylyl cyclase. Elevated cGMP levels, in turn, can enhance vomeronasal 1 receptor 128 signaling by influencing cGMP-dependent protein kinases. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium nitroprusside releases nitric oxide, which activates guanylyl cyclase, resulting in increased cGMP levels that can indirectly enhance the activity of vomeronasal 1 receptor 128 through cGMP-dependent protein kinases. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases, potentially enhancing the activity of vomeronasal 1 receptor 128 through calcium-dependent signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases that elevates cAMP and cGMP by preventing their degradation, leading to an enhanced activity of PKA and PKG which can indirectly increase vomeronasal 1 receptor 128 functional activity. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator that, upon hydrolysis inside the cell, selectively binds to calcium. This can lead to compensatory cellular mechanisms that enhance calcium influx, potentially increasing vomeronasal 1 receptor 128 activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a non-selective beta-adrenergic agonist that increases cAMP levels in the cell by activating adenylate cyclase, which can enhance vomeronasal 1 receptor 128 signaling by activating PKA and subsequent phosphorylation of associated proteins. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase 5, leading to an increase in cGMP levels that can enhance signaling through cGMP-dependent protein kinases, indirectly increasing vomeronasal 1 receptor 128 activity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine is a phosphodiesterase inhibitor, which can increase intracellular cAMP and cGMP by preventing their breakdown, thereby enhancing PKA and PKG activity which can indirectly activate vomeronasal 1 receptor 128. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Niflumic acid is a chloride channel blocker that can alter membrane potential and cellular ionic balance, potentially leading to compensatory mechanisms that enhance calcium signaling and increase vomeronasal 1 receptor 128 activity. | ||||||